Introduction to Market Access for Pharmaceuticals

Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the correct purchasers, the drug will fail to reach its intended market. This practical guide, from the European Market Access University Diploma (EMAUD), helps readers draft a market access strategy for their product and prepare a positive healthcare environment that supports uptake of the product, including pricing considerations.